Ionis Pharmaceuticals, Inc.
IONS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $242 | $399 | $276 | $869 |
| Short-Term Investments | $2,056 | $1,932 | $1,721 | $1,264 |
| Receivables | $92 | $98 | $26 | $62 |
| Inventory | $13 | $7 | $22 | $25 |
| Other Curr. Assets | $218 | $205 | $158 | $125 |
| Total Curr. Assets | $2,620 | $2,642 | $2,203 | $2,345 |
| Property Plant & Equip (Net) | $256 | $243 | $256 | $196 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $29 |
| Long-Term Investments | $41 | $43 | $40 | $32 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $86 | $62 | $35 | $9 |
| Total NC Assets | $383 | $348 | $331 | $267 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,004 | $2,990 | $2,534 | $2,612 |
| Liabilities | – | – | – | – |
| Payables | $43 | $26 | $18 | $12 |
| Short-Term Debt | $9 | $53 | $8 | $4 |
| Tax Payable | $0 | $2 | $6 | $0 |
| Deferred Revenue | $79 | $151 | $91 | $98 |
| Other Curr. Liab. | $178 | $216 | $189 | $127 |
| Total Curr. Liab. | $309 | $448 | $312 | $241 |
| LT Debt | $1,407 | $1,400 | $1,362 | $1,248 |
| Deferred Rev, NC | $157 | $241 | $288 | $352 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $542 | $514 | $0 | $352 |
| Total NC Liab. | $2,106 | $2,155 | $1,649 | $1,599 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $162 | $171 | $179 | $19 |
| Total Liabilities | $2,415 | $2,603 | $1,961 | $1,840 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,250 | -$1,796 | -$1,430 | -$1,160 |
| AOCI | -$31 | -$33 | -$57 | -$33 |
| Other Equity | $2,869 | $2,215 | $2,060 | $1,964 |
| Total Equity | $588 | $387 | $573 | $772 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,004 | $2,990 | $2,534 | $2,612 |
| Net Debt | $1,174 | $1,054 | $1,093 | $382 |